Vellore, India

Kamalraj Thiyagarajan

This inventor holds 5 USPTO granted patents and 1 published patent application and 5 EPO patents. Top assignee: Bristol-Myers Squibb Compnay. Active years: 2019-2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kamalraj Thiyagarajan. Retrieved from https://idiyas.com/inventor/kamalraj-thiyagarajan

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 5 

% Patents Active = 100.0

 

Average Co-Inventor Count = 6.5

ph-index = 1

Forward Citations = 5(Granted Patents)


Location History:

  • Gudiyattam, IN (2019)
  • Vellore, IN (2020 - 2023)

Company Filing History:


Years Active: 2019-2023

Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: Kamalraj Thiyagarajan: Innovator in Selective ROCK Inhibitors

Introduction

Kamalraj Thiyagarajan is a notable inventor based in Vellore, India. He has made significant contributions to the field of pharmaceuticals, particularly in the development of selective ROCK inhibitors. With a total of 5 patents to his name, Thiyagarajan's work is paving the way for advancements in treating various disorders.

Latest Patents

Thiyagarajan's latest patents focus on 5-membered and bicyclic heterocyclic amides as inhibitors of ROCK. The present invention provides compounds of Formula (I) or stereoisomers, tautomers, or pharmaceutically-acceptable salts thereof, wherein all the variables are as defined herein. These compounds are selective ROCK inhibitors. This invention also relates to pharmaceutical compositions comprising these compounds and methods of treating cardiovascular, smooth muscle, oncologic, neuropathologic, autoimmune, fibrotic, and/or inflammatory disorders using the same.

Career Highlights

Kamalraj Thiyagarajan is currently associated with Bristol-Myers Squibb Company, where he continues to innovate and contribute to the pharmaceutical industry. His work is instrumental in developing new therapeutic options for patients suffering from various health conditions.

Collaborations

Thiyagarajan has collaborated with notable colleagues such as Peter W. Glunz and Tarun Kumar Maishal. These collaborations have further enhanced the research and development efforts in the field of selective ROCK inhibitors.

Conclusion

Kamalraj Thiyagarajan is a distinguished inventor whose work in selective ROCK inhibitors is making a significant impact in the pharmaceutical industry. His contributions are vital for the advancement of treatments for various disorders, showcasing the importance of innovation in healthcare.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…